Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001204.7(BMPR2):c.968-3C>G

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA645293968

425852 (ClinVar)

Gene: BMPR2

Condition: pulmonary arterial hypertension

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: f792e131-225a-409f-af59-2939d0c0e1d2

Approved on: 2024-05-03

Published on: 2024-05-03

HGVS expressions

NM_001204.7:c.968-3C>G

NM_001204.7(BMPR2):c.968-3C>G

NC_000002.12:g.202530791C>G

CM000664.2:g.202530791C>G

NC_000002.11:g.203395514C>G

CM000664.1:g.203395514C>G

NC_000002.10:g.203103759C>G

NG_009363.1:g.159465C>G

ENST00000374580.10:c.968-3C>G

ENST00000638587.1:c.899-3C>G

ENST00000374574.2:c.968-3C>G

ENST00000374580.8:c.968-3C>G

NM_001204.6:c.968-3C>G

Uncertain Significance

PP3 PS4_Supporting PM2_Supporting

Evidence Links 0

Expert Panel

Pulmonary Hypertension VCEP

Criteria Specification Information

Criteria Specification: ClinGen Pulmonary Hypertension Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for BMPR2 Version 1.1.0

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Pulmonary Hypertension VCEP

The BMPR2 c.968-3C>G is an intronic variant in intron 7. This variant is absent from both gnomAD v2.1.1 and v3.1.2 (PM2_Supporting). The variant has been reported in 2 unrelated PAH patients (PMID: 26387786 and GeneDx submission to ClinVar) (PS4_Supporting). PVS1 is not applied because it is a non-canonical splice site variant without mRNA processing data. The computational splicing predictor SpliceAI gives a score of 0.98 for acceptor loss, predicting that the variant disrupts the acceptor splice site of intron 7 (PP3). In summary, the variant is classified as a variant of uncertain significance for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PM2_supporting, PS4_supporting, PP3 (VCEP specification version 1.1, 1/18/2024).

PP3

The computational splicing predictor SpliceAI gives a score of 0.98 for acceptor loss, predicting that the variant disrupts the acceptor splice site of intron 7 of BMPR2.

PS4_Supporting

The variant has been reported in 2 unrelated PAH patients: first proband is associated with the publication (PMID: 26387786) and the second proband, with no further information for co-segregation, is from an internal lab contributor GeneDx (PS4_Supporting).

PM2_Supporting

The variant is absent from both gnomAD v2.1.1 and v3.1.2.

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.